Author details

Full Name

Federico Canzian

Affiliation

ORCID

Career Start Year

1993

Papers

338

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
36719829	Phylogenetic origin of Helicobacter pylori pathogenicity island and risk of stomach cancer and high-grade premalignant gastric lesions.		2023
36082445	A pleiotropic variant in DNAJB4 is associated with multiple myeloma risk.	Int J Cancer	2023
37944693	The local environment and germline genetic variation predict cancer risk in the UK Biobank prospective cohort.		2023
37670727	A scan of all coding region variants of the human genome, identifies 13q12.2-rs9579139 and 15q24.1-rs2277598 as novel risk loci for pancreatic ductal adenocarcinoma.	Carcinogenesis	2023
37723249	Identification of novel genetic loci for risk of multiple myeloma by functional annotation.	Leukemia	2023
37574541	Exploring the Neandertal legacy of pancreatic ductal adenocarcinoma risk in Eurasians.	Biol Res	2023
37985251	Analysis of exposome and genetic variability suggests stress as a major contributor for development of pancreatic ductal adenocarcinoma.		2023
37346070	Role of pancreatic ductal adenocarcinoma risk factors in intraductal papillary mucinous neoplasm progression.		2023
36973108	Genetic and non-genetic risk factors for early-onset pancreatic cancer.	Dig Liver Dis	2023
37130759	Polymorphic variants involved in methylation regulation: a strategy to discover risk loci for pancreatic ductal adenocarcinoma.	J Med Genet	2023
37239846	Polymorphisms within Autophagy-Related Genes as Susceptibility Biomarkers for Multiple Myeloma: A Meta-Analysis of Three Large Cohorts and Functional Characterization.	Int J Mol Sci	2023
37175717	Do GWAS-Identified Risk Variants for Chronic Lymphocytic Leukemia Influence Overall Patient Survival and Disease Progression?		2023
37047000	GWAS-Identified Variants for Obesity Do Not Influence the Risk of Developing Multiple Myeloma: A Population-Based Study and Meta-Analysis.		2023
37164172	The PANcreatic Disease ReseArch (PANDoRA) consortium: Ten years' experience of association studies to understand the genetic architecture of pancreatic cancer.	Crit Rev Oncol Hematol	2023
36451333	Association between a polymorphic variant in the CDKN2B-AS1/ANRIL gene and pancreatic cancer risk.	Int J Cancer	2023
37539667	Genome-wide study of genetic polymorphisms predictive for outcome from first-line oxaliplatin-based chemotherapy in colorectal cancer patients.	Int J Cancer	2023
37503126	Understanding the genetic complexity of puberty timing across the allele frequency spectrum.	medRxiv	2023
37351909	Genetic Susceptibility to Nonalcoholic Fatty Liver Disease and Risk for Pancreatic Cancer: Mendelian Randomization.	Cancer Epidemiol Biomarkers Prev	2023
34653070	TAS2R38 polymorphisms, Helicobacter pylori infection and susceptibility to gastric cancer and premalignant gastric lesions.	European Journal of Cancer Prevention	2022
36303815	A genome-wide gene-based gene-environment interaction study of breast cancer in more than 90,000 women.	Cancer Res Commun	2022
36302831	Common variability in oestrogen-related genes and pancreatic ductal adenocarcinoma risk in women.	Sci Rep	2022
35581176	Validation and functional characterization of GWAS-identified variants for chronic lymphocytic leukemia: a CRuCIAL study.	Blood Cancer Journal	2022
36291856	Autophagy in Hematological Malignancies.	Cancers	2022
35700034	Does a Multiple Myeloma Polygenic Risk Score Predict Overall Survival of Patients with Myeloma?	Cancer Epidemiol Biomarkers Prev	2022
36212403	Impact of genetic polymorphisms of drug transporters and and regulators of xenobiotic transport and metabolism and on clinical efficacy of dasatinib in chronic myeloid leukemia.	Frontiers in Oncology	2022
36328784	Physical activity, sedentary time and breast cancer risk: a Mendelian randomisation study.	Br J Sports Med	2022
35984985	Predictive Polygenic Score for Outcome after First-Line Oxaliplatin-Based Chemotherapy in Colorectal Cancer Patients Using Supervised Principal Component Analysis.	Cancer Epidemiol Biomarkers Prev	2022
35472852	Genetically Determined Telomere Length Is Associated with Pancreatic Neuroendocrine Neoplasms Onset.	Neuroendocrinology	2022
35723569	Distinct Reproductive Risk Profiles for Intrinsic-Like Breast Cancer Subtypes: Pooled Analysis of Population-Based Studies.	J Natl Cancer Inst	2022
32818625	Germline genetic variability in pancreatic cancer risk and prognosis.	Seminars in Cancer Biology	2022
34862210	Validation of Genetic Markers Associated with Survival in Colorectal Cancer Patients Treated with Oxaliplatin-Based Chemotherapy.	Cancer Epidemiol Biomarkers Prev	2022
34964454	Genome-wide association study of mitochondrial copy number.	Human Molecular Genetics	2022
34845334	A polygenic risk score for multiple myeloma risk prediction.	European Journal of Human Genetics	2022
34526302	Genetic Polymorphisms Involved in Mitochondrial Metabolism and Pancreatic Cancer Risk.	Cancer Epidemiol Biomarkers Prev	2021
32359158	Combined Associations of a Polygenic Risk Score and Classical Risk Factors With Breast Cancer Risk.	J Natl Cancer Inst	2021
33854038	Genetically determined telomere length and multiple myeloma risk and outcome.	Blood Cancer Journal	2021
33534179	Genome-wide scan of long noncoding RNA single nucleotide polymorphisms and pancreatic cancer susceptibility.	Int J Cancer	2021
33675538	Expression quantitative trait loci of genes predicting outcome are associated with survival of multiple myeloma patients.	Int J Cancer	2021
33574088	Smoking Modifies Pancreatic Cancer Risk Loci on 2q21.3.	Cancer Res	2021
34216462	Associations between pancreatic expression quantitative traits and risk of pancreatic ductal adenocarcinoma.	Carcinogenesis	2021
34146516	Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element.	Am J Hum Genet	2021
33879152	Susceptibility loci for pancreatic cancer in the Brazilian population.	BMC Med Genomics	2021
33828170	Lack of association of CD44-rs353630 and CHI3L2-rs684559 with pancreatic ductal adenocarcinoma survival.	Sci Rep	2021
33500318	Breast Cancer Risk Factors and Survival by Tumor Subtype: Pooled Analyses from the Breast Cancer Association Consortium.	Cancer Epidemiol Biomarkers Prev	2021
34341517	Mendelian randomisation study of smoking exposure in relation to breast cancer risk.	Br J Cancer	2021
33152124	Common gene variants within 3'-untranslated regions as modulators of multiple myeloma risk and survival.	Int J Cancer	2021
33038278	Do myeloproliferative neoplasms and multiple myeloma share the same genetic susceptibility loci?	International Journal of Cancer	2021
32591343	Polygenic and multifactorial scores for pancreatic ductal adenocarcinoma risk prediction.	J Med Genet	2021
33128820	Association between anthropometry and lifestyle factors and risk of B-cell lymphoma: An exposome-wide analysis.	International Journal of Cancer	2021
34926279	Identification of Recessively Inherited Genetic Variants Potentially Linked to Pancreatic Cancer Risk.	Front Oncol	2021